Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Knockdown stands up.

P Mathijs Voorhoeve1, Reuven Agami

  • 1Division of Tumor Biology and Center for Biomedical Genetics, The Netherlands Cancer Institute, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.

Trends in Biotechnology
|December 14, 2002
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Histidine to glutamine substitutants, a regulated process that impacts cell survival and suggests histidine shortage in cancer.

Cell death discovery·2026
Same author

Arginine Deprivation of ASS1-Deficient Cancers Drives Mistranslation and Shared Neoepitope Production.

Cancer research·2026
Same author

Aspartyl-tRNA synthetase 1 (DARS1) reshapes hepatocellular carcinoma proteome and promotes aggressiveness through noncanonical SAGA-MYC signaling modulation.

Hepatology (Baltimore, Md.)·2026
Same author

MHC1-TIP enables single-tube multimodal immunopeptidome profiling and uncovers intratumoral heterogeneity in antigen presentation.

Communications biology·2026
Same author

Exploiting nanopore sequencing advances for tRNA sequencing of human cancer models.

NAR cancer·2025
Same author

Upstream open reading frame translation enhances immunogenic peptide presentation in mitotically arrested cancer cells.

Nature communications·2025
Same journal

Smart biomaterials: From responsiveness to closed-loop sensing and feedback.

Trends in biotechnology·2026
Same journal

Bacterial spores as a modular platform for the production of amyloids for materials.

Trends in biotechnology·2026
Same journal

The oriGen case and Mexico's regulatory blind spots in genomic biobanking.

Trends in biotechnology·2026
Same journal

A caspase-3-activated protein expression system for apoptosis visualization and apoptosis-pyroptosis conversion to boost antitumor activity.

Trends in biotechnology·2026
Same journal

Over 4 months of ethylene production using solid-state photosynthetic cell factories.

Trends in biotechnology·2026
Same journal

Closing the nitrogen loop in groundwater with biohybrid technologies.

Trends in biotechnology·2026
See all related articles

RNA interference (RNAi) technology allows for selective gene inactivation in mammalian cells. Recent studies demonstrate RNAi

Area of Science:

  • Genetics
  • Molecular Biology
  • Biotechnology

Background:

  • RNA interference (RNAi) is a natural process in organisms like worms and plants.
  • RNAi utilizes double-stranded RNA to selectively inactivate genes by degrading messenger RNA (mRNA).
  • The application of RNAi in mammalian cells in vitro has advanced genetic research.

Purpose of the Study:

  • To explore the potential of RNA interference (RNAi) for gene suppression in mammals.
  • To highlight the implications of in vivo RNAi in mammalian systems for research and therapeutic development.

Main Methods:

  • Review of recent scientific literature on RNA interference (RNAi) in mammalian systems.
  • Analysis of studies demonstrating gene suppression in vivo using RNAi technology.

Related Experiment Videos

Main Results:

  • Two recent publications confirm the feasibility of gene suppression in vivo in mammals via RNAi.
  • RNA interference (RNAi) has been successfully applied to inactivate genes within living mammalian organisms.

Conclusions:

  • RNA interference (RNAi) is a powerful tool for selective gene inactivation in mammalian research.
  • The in vivo application of RNAi in mammals holds significant promise for future therapeutic strategies and biological research.